PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson's Disease
TORONTO, May 02, 2023 -- PharmaTher Holdings Ltd. , a specialty pharmaceutical company, today announced the submission of a Fast Track Application to the U.S. Food and Drug Administration for... | May 2, 2023
Fabio Chianelli Pharmather Holdings Ltd Regulation Services Provider Company Or Pharmather Neither The Canadian Securities Exchange Drug Administration
Source: marketscreener.com